Related Experiment Video
Updated: Apr 26, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Risk factors for the development of Clostridium difficile infection in hospitalized children
Waheeda Samady1, Alice Pong, Erin Fisher
1aFeinberg School of Medicine, Northwestern University bAnn and Robert H. Lurie Children's Hospital, Chicago, Illinois cDivision of Infectious Diseases, University of California dRady Children's Hospital eDivision of Hospital Medicine, University of California, San Diego, California, USA.
Insights
Recent antibiotic exposure and prolonged hospitalization are key risk factors for Clostridium difficile infection (CDI) in children. While common, severe CDI outcomes are infrequent in this pediatric population.
Area of Science:
- Pediatric Infectious Diseases
- Hospital Epidemiology
- Microbiology
Background:
- Clostridium difficile infection (CDI) epidemiology is evolving in both adult and pediatric populations.
- Understanding current risk factors for pediatric CDI is crucial for effective prevention and management.
Purpose of the Study:
- To define the primary risk factors for Clostridium difficile infection (CDI) in hospitalized children.
- To review recent studies on pediatric CDI epidemiology and risk factors.
Main Methods:
- Literature review of recent studies on pediatric Clostridium difficile infection.
- Analysis of identified risk factors including antibiotic exposure, hospitalization duration, and comorbid conditions.
Main Results:
- Antibiotic exposure within 4-12 weeks was a significant risk factor in most pediatric CDI cases.
- Prolonged or past hospitalization increases risk due to potential C. difficile spore exposure.
- Comorbidities like cancer and inflammatory bowel disease are strongly associated with pediatric CDI.
Conclusions:
- Antibiotic use and hospitalization duration remain critical risk factors for pediatric CDI.
- Children with malignancy or inflammatory bowel disease face elevated CDI risk.
- Severe CDI outcomes and resistant infections are uncommon in pediatric patients.
Purpose Of Review:
This article defines the risk factors for Clostridium difficile infection (CDI) in hospitalized children in light of recent studies demonstrating a change in the epidemiology of these infections in both adults and children.
Recent Findings:
Antibiotic exposure within the past 4-12 weeks was noted in a majority of published cases of pediatric CDI, and that remains a key risk factor for infection. Past and/or prolonged hospitalization increase a child's risk for CDI as they increase potential contact with C. difficile spores. Of all CDI, hospital-acquired infection remains more common. Many comorbid conditions have been linked with CDI, with the strongest association existing in children with cancer and inflammatory bowel disease. Severe infections occur infrequently in pediatric patients. Markers established in adults for severe CDI resulting in colectomy or transfer to ICU have not been shown to correlate in pediatric patients.
Summary:
Recent antibiotic exposure and hospitalization remain key risk factors for CDI in the hospitalized pediatric patient. Patients with comorbid conditions such as malignancy and inflammatory bowel disease are at higher risk for CDI. Resistant infections and severe outcomes are not common in the pediatric population.
More Related Videos
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Development of Human Microbiota
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Bacterial Gastroenteritis
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Inflammatory Bowel Disease III: Crohn's Disease

